Antibiotic

Product NDC: 55550-730
11-digit product format: 555500730
Labeler code: 55550
Product ID: 55550-730_5cf31e3a-83a6-48dd-9396-dcc812cd8cbf
Type: HUMAN OTC DRUG
Nonproprietary name: neomycin sulfate
Dosage form: OINTMENT
Route: TOPICAL
Labeler: Total Resources International
Application: M004
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2019-10-07
Substance: NEOMYCIN SULFATE
Active strength: 3.5 mg/g
Pharmacologic classes: Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	55550-730-21	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	55550-730-21	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	55550-730-21	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	55550-730-21	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	55550-730-21	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	55550-730-21	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	55550-730-21	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	55550-730-21	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	55550-730-21	`8dfbde2a14a4…`	`c9ff85d89658…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Antibiotic
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
NEOMYCIN SULFATE	3.5 mg/g

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
057Y626693	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
311928	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
0725364b-b243-4891-af2f-a6049366d038	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
99e684e6-f435-feb8-d2bb-3a546f1cb768	Product name	2	20161117
b045ad64-0f28-9a02-2f9b-b34d94fb2278	Product name	1	20140508
b6082387-f592-1148-0844-bd068fd213fb	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

Effective, Related label table
Effective	Related label
2024-10-03	0725364b-b243-4891-af2f-a6049366d038
2024-10-03	0725364b-b243-4891-af2f-a6049366d038
2024-01-30	0725364b-b243-4891-af2f-a6049366d038
2024-01-30	0725364b-b243-4891-af2f-a6049366d038
2022-12-19	0725364b-b243-4891-af2f-a6049366d038
2022-12-19	0725364b-b243-4891-af2f-a6049366d038
2021-01-29	0725364b-b243-4891-af2f-a6049366d038
2021-01-29	0725364b-b243-4891-af2f-a6049366d038

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
55550-730-21	Antibiotic	0.9 g in 1 POUCH	OINTMENT	0.9		4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
55550-730	ANTIBIOTIC (NEOMYCIN SULFATE) OINTMENT [TOTAL RESOURCES INTERNATIONAL]	3	Current NDC, Legacy NDC, 1 package rows	20241004_0725364b-b243-4891-af2f-a6049366d038.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 18 of 22 · 424 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Major Triple Antibiotic	BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B SULFAT	Major Pharmaceuticals	a6cc3fbc-6302-4033-e053-2a95a90a19f0	2024-09-11	Warnings	Exact identifier application number: M004
Leader Triple antibiotic	BACITRACIN,NEOMYCIN,POLYMXIN	Cardinal Health 110 dba LEADER	2175e00a-bf85-3377-e063-6394a90a916f	2024-09-06	Warnings	Exact identifier application number: M004
Members Mark Triple Antibiotic	BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B	Sam's West Inc	200f4020-7699-4a9e-8fab-2d3df9e76836	2024-09-05	Warnings	Exact identifier application number: M004
Leader Poly Bacitracin	BACITRACIN ZINC POLYMIXIN B SULFATE	Cardinal Health 110 dba LEADER	20d7624f-cafa-25e1-e063-6394a90a4439	2024-08-29	Warnings	Exact identifier application number: M004
triple antibiotic	BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B	Meijer Distribution Inc	edcb423e-b5c2-4e26-8f7f-9b9ee575042c	2024-08-19	Warnings	Exact identifier application number: M004
Major Clotrimazole	CLOTRIMAZOLE	NuCare Pharmaceuticals,Inc.	562dfc9f-1897-330a-e054-00144ff8d46c	2024-08-14	Warnings	Exact identifier application number: M004
Triple Antibiotic	BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	Wildeman Business Group	1f96450a-3bda-1f0a-e063-6294a90a514f	2024-08-13	Warnings	Exact identifier application number: M004
Triple Antibiotic	BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	Provision Medical	bbf4b99c-9738-4855-82a6-f4e213924ec9	2024-08-09	Warnings	Exact identifier application number: M004
Tetracyte Topical Tetracycline Hydrochloride	TETRACYCLINE HYDROCHLORIDE	VIADERMA DISTRIBUTION INC	4ac5177d-bb67-45e6-adcf-44f0821746bd	2024-08-01	Warnings	Exact identifier application number: M004
Bacitracin	BACITRACIN	Padagis Israel Pharmaceuticals Ltd	bebbedf6-dd65-47a4-aa3e-ad197b3e05a1	2024-07-31	Warnings	Exact identifier application number: M004
Bacitracin Zinc	BACITRACIN ZINC	Chain Drug Marketing Association Inc.	1cd9ded3-068c-496e-e063-6394a90a6a0b	2024-07-09	Warnings	Exact identifier application number: M004
Anti-Itch with Aloe	HYDROCORTISONE 1%	Chain Drug Marketing Association Inc.	1cbea7cd-03a0-1469-e063-6294a90a7cc1	2024-07-08	Warnings	Exact identifier application number: M004
astonea First Aid	BACITRACIN ZINC	ASTONEA LABS PRIVATE LIMITED	de0b2e06-64bc-78f0-e053-2995a90a39a0	2024-06-25	Warnings	Exact identifier application number: M004
Publix Bacitracin Zinc	BACITRACIN ZINC	PUBLIX SUPER MARKETS, INC.	51f21123-7826-40c9-b2aa-b202125085e2	2024-06-17	Warnings	Exact identifier application number: M004
Publix Triple Antibiotic	BACITRACIN ZINC 400 U, POLYMXYIN B SULFATE 5,000 U, NEOMYCIN SULFATE 3.5MG/G	PUBLIX SUPER MARKETS, INC.	871fa43c-a1be-4c15-bbfa-a998a2d89d2e	2024-06-17	Warnings	Exact identifier application number: M004
Biofreeze Professional	MENTHOL, UNSPECIFIED FORM	NuCare Pharmaceuticals,Inc.	66ff9726-20da-688a-e053-2a91aa0a59ac	2024-06-06	Warnings	Exact identifier application number: M004
QC Triple Antibiotic	BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE.	Chain Drug Marketing Association	1a1501a4-75b0-5900-e063-6394a90ad77a	2024-06-04	Warnings	Exact identifier application number: M004
Always Save Bacitracin Zinc	BACITRACIN ZINC	Trifecta Pharmaceuticals USA LLC	1a00df31-a38a-fc82-e063-6394a90abbf3	2024-06-03	Warnings	Exact identifier application number: M004
PENTREXCILINA TRIPLE ANTIBIOTIC PLUS PAIN RELIEF	BACITRACIN, NEOMYCIN, POLYMYXIN B, PRAMOXINE	OPMX LLC	7c0d3cdf-af50-4a65-a01b-a33510feeb94	2024-05-17	Warnings	Exact identifier application number: M004
PENIMIXCINA	BACITRACIN, NEOMYCIN SULFATE, POLYMIXIN B SULFATE, PRAMOXINE HYDROCHLORIDE	OPMX LLC	92bcbc02-9683-4117-af2b-6d4687796f1f	2024-05-17	Warnings	Exact identifier application number: M004

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
057Y626693	NEOMYCIN SULFATE	1405-10-3	NEOMYCIN SULFATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
311928	neomycin 0.35 % Topical Ointment	PSN	0725364b-b243-4891-af2f-a6049366d038	4
311928	neomycin 0.0035 MG/MG Topical Ointment	SCD	0725364b-b243-4891-af2f-a6049366d038	4
311928	neomycin (as neomycin sulfate 5 MG per 1 GM) 3.5 MG per 1 GM Topical Ointment	SY	0725364b-b243-4891-af2f-a6049366d038	4
311928	neomycin 0.35 % Topical Ointment	SY	0725364b-b243-4891-af2f-a6049366d038	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
55550-730-21	55550073021	.9 g in 1 POUCH (55550-730-21)	2019-10-07	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Antibiotic - Total Resources International	Total Resources International	2025-10-10	HUMAN OTC DRUG LABEL	4